Dr. Peter Attia discusses colorectal cancer (CRC) screening, emphasizing that CRC is one of the most preventable cancers due to its slow progression and the ability of colonoscopy to both detect and remove precancerous lesions. He highlights the rise in early-onset CRC, the importance of starting screening earlier, and the limitations of non-invasive tests like stool-based and blood-based options.
Summarized by Podsumo
Colonoscopy is uniquely valuable because it can both screen for and prevent cancer by removing precancerous polyps, unlike mammograms or CT scans.
Approximately 68% of CRC deaths could be prevented with current screening, but Attia argues this could be near 100% with more aggressive protocols, including starting earlier.
There is a troubling rise in early-onset colorectal cancer among younger adults, prompting a discussion on when to start screening.
Non-invasive screening options (stool tests, blood tests) are growing but have limitations; they cannot prevent cancer by removing lesions like colonoscopy can.
"A colonoscopy can not only detect those precancerous lesions, but also remove them before they ever become cancer. So no other common cancer screening test can make that claim."
"We're talking about a cancer that in most cases gives us a decades-long window to intervene, and we're still losing nearly 70% of people out of that 55,000 deaths a year because they never walked through the front door to get a colonoscopy."
"The goal here is to leave you with a very clear, practical picture of colorectal cancer screening, whether you're 35 and wondering when to start, or 55 and wondering when your cologard test is good enough."